Viekira PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), Co-packaged for Oral Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
USE IN SPECIFIC POPULATIONS
Pregnancy
Animal data
Ombitasvir
Ombitasvir was administered orally to...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts